Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.20B | 37.54B | 41.78B | 43.84B | 54.50B | 39.55B |
Gross Profit | 13.17B | 13.60B | 17.70B | 19.81B | 32.77B | 21.98B |
EBITDA | 13.49B | 11.07B | 15.56B | 23.74B | 35.76B | 14.43B |
Net Income | 5.82B | 5.86B | 7.98B | 18.79B | 22.45B | 4.88B |
Balance Sheet | ||||||
Total Assets | 83.43B | 80.25B | 94.19B | 86.89B | 89.44B | 92.01B |
Cash, Cash Equivalents and Short-Term Investments | 4.00B | 5.01B | 3.66B | 4.80B | 11.90B | 14.26B |
Total Debt | 18.55B | 17.74B | 16.80B | 15.44B | 17.20B | 21.49B |
Total Liabilities | 47.07B | 45.69B | 53.20B | 49.54B | 54.14B | 57.19B |
Stockholders Equity | 35.21B | 33.43B | 39.46B | 35.39B | 34.47B | 35.74B |
Cash Flow | ||||||
Free Cash Flow | 1.15B | 2.92B | 7.25B | 6.04B | 20.65B | 10.10B |
Operating Cash Flow | 7.46B | 9.37B | 13.16B | 11.48B | 25.68B | 14.32B |
Investing Cash Flow | -5.22B | -5.79B | -6.49B | -4.69B | -6.61B | -4.67B |
Financing Cash Flow | -1.78B | -2.13B | -7.41B | -13.91B | -20.28B | -2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $138.75B | 15.32 | 19.51% | 4.00% | -7.86% | 14.17% | |
75 Outperform | $107.70B | 10.07 | 18.18% | 5.85% | -0.44% | -4.20% | |
74 Outperform | $44.34B | 8.64 | 13.49% | 7.67% | -12.89% | -46.86% | |
61 Neutral | $10.37B | 6.45 | -0.08% | 2.84% | 3.09% | -36.03% | |
60 Neutral | $11.17B | ― | -9.57% | ― | 39.42% | -172.40% | |
48 Neutral | $784.16M | ― | -40.17% | 1.61% | 7.27% | 27.35% | |
48 Neutral | $641.00M | ― | -9.63% | 2.09% | 8.66% | 66.06% |